WBABy Calypso Research4 min read

Walgreens Boots Alliance (WBA) Q4 2024 Earnings Analysis

A Dose of Good News with $39.5B for Walgreens

Key Takeaways

Walgreens Boots Alliance (WBA) reported Q4 2024 earnings with revenue of $39.5B, representing a +7.5% year-over-year change. The stock moved +27.5% on earnings day.

The bull case: Contract renegotiations and pharmacy optimization initiatives set the stage for long-term margin stabilization and cash flow improvement.

The bear case: Near-term headwinds from retail sales decline, store closures, and legal payments could impede a swift turnaround.

Financial Highlights

  • Revenue: $39.5B (+7.5% YoY)
  • Gross Profit: $6.8B (17.2% margin, -1.3% YoY)
  • Operating Income: $-236M (-0.6% margin, -0.5% YoY)
  • Net Income: $-265M
  • TTM Revenue: $150.4B

Stock Performance

  • Earnings Day Move: +27.5%
  • Year-to-Date: +30.4%
  • 1-Year Return: +10.7%
  • vs. S&P 500 (since earnings): +31.3%
  • vs. Nasdaq (since earnings): +28.7%

View live WBA data, AI chat, and interactive debates on Calypso →

What Management Said

Here are the key debates and direct quotes from Walgreens Boots Alliance's Q4 2024 earnings call:

Reimbursement Dynamics and Contract Negotiation Outcomes

Sentiment: Positive

"2024 was a very important year for it [contract renegotiations], and we are very pleased with that start on the three-year process." — Tim Wentworth

Store Closures and Footprint Optimization

Sentiment: Positive

"We expect $100 million in AOI benefit from the footprint optimization program...these benefits will scale over time as we continue down the path over a three-year plan." — Manmohan Mahajan

Cash Flow Stabilization and Asset Monetization

Sentiment: Positive

"Our focus on a sustained positive free cash flow and doing the things we have to do in order to achieve that are front and center for us, and it is a multiyear process." — Tim Wentworth

Front-End Retail Strategy and Consumer Behavior

Sentiment: Mixed

"Own brand penetration is up to 17.8%, and we introduced approximately 60 new owned brand products in the first quarter." — Tim Wentworth

Role of Micro-Fulfillment Centers (MFCs) in Pharmacy Operations

Sentiment: Positive

"Over the next 12 months, we will get closer to 6,000 stores on the platform, allowing us to use automation to enhance pharmacy operations and patient care." — Tim Wentworth

Bull Case

Contract renegotiations and pharmacy optimization initiatives set the stage for long-term margin stabilization and cash flow improvement.

Bear Case

Near-term headwinds from retail sales decline, store closures, and legal payments could impede a swift turnaround.

Looking Ahead

Investors will be closely watching Walgreens Boots Alliance's next quarterly report for continued execution, particularly around reimbursement Dynamics and Contract Negotiation Outcomes. With operating margins at -0.6%, margin trends will remain a focal point. The market's positive reaction on earnings day suggests confidence in management's direction, and the next earnings report will be a key catalyst for the stock.

Frequently Asked Questions

What was Walgreens Boots Alliance's revenue in Q4 2024?

Walgreens Boots Alliance reported Q4 2024 revenue of $39.5B, representing a +7.5% year-over-year change.

Did Walgreens Boots Alliance beat earnings expectations in Q4 2024?

The stock rose +27.5% on earnings day, suggesting the results met or exceeded market expectations. The current bull case centers on: Contract renegotiations and pharmacy optimization initiatives set the stage for long-term margin stabilization and cash flow improvement.

What is the bull case for WBA stock?

The bull case for WBA centers on: Contract renegotiations and pharmacy optimization initiatives set the stage for long-term margin stabilization and cash flow improvement.

What is the bear case for WBA stock?

The bear case for WBA centers on: Near-term headwinds from retail sales decline, store closures, and legal payments could impede a swift turnaround.

How has WBA stock performed since its Q4 2024 earnings?

WBA moved +27.5% on the day of its Q4 2024 earnings report, outperforming the S&P 500 by +31.3% since earnings. Year-to-date, the stock has returned +30.4%.

Browse all 400+ earnings reports →

Learn More

Analyze WBA in Real Time

This is a static snapshot. For live financial data, AI-powered chat, and interactive earnings debates for Walgreens Boots Alliance and 400+ other stocks, explore the full platform.

Open WBA on Calypso →

Calypso is an AI-powered equity research platform used by investment teams to cut earnings research time by over 80%.